Diabetes phenotypes: Beyond IDDM vs NIDDM

Affiliations

Editorial

Zachary Bloomgarden et al. J Diabetes. 2019 Sep.

. 2019 Sep;11(9):698-699.

doi: 10.1111/1753-0407.12954. Epub 2019 Jun 21.

No abstract available

Comment on

Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables.
Ahlqvist E, Storm P, Käräjämäki A, Martinell M, Dorkhan M, Carlsson A, Vikman P, Prasad RB, Aly DM, Almgren P, Wessman Y, Shaat N, Spégel P, Mulder H, Lindholm E, Melander O, Hansson O, Malmqvist U, Lernmark Å, Lahti K, Forsén T, Tuomi T, Rosengren AH, Groop L. Ahlqvist E, et al. Lancet Diabetes Endocrinol. 2018 May;6(5):361-369. doi: 10.1016/S2213-8587(18)30051-2. Epub 2018 Mar 5. Lancet Diabetes Endocrinol. 2018. PMID: 29503172

1. Ahlqvist E, Storm P, Käräjämäki A, et al. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol. 2018;6:361-369.
1. Levy JC. Interpretation of HOMA indices. https://www.dtu.ox.ac.uk/homacalculator/HOMANoNormalRange.pdf. Accessed May 12, 2019.
1. Zou X, Zhou X, Zhu Z, Ji L. Novel subgroups of patients with adult-onset diabetes in Chinese and US populations. Lancet Diabetes Endocrinol. 2019;7:9-11.
1. Dennis JM, Shields BM, Henley WE, Jones AG, Hattersley AT. Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data. Lancet Diabetes Endocrinol. 2019;7:442-451. https://doi.org/10.1016/S2213-8587(19)30087-7.
1. Bloomgarden Z, Chilton R. Lipids as risk markers for type 2 diabetes. J Diabetes. 2019;11:176-178.